Nathaniel W.; and Grabel, Laura, "Embryonic stem cell-derived neural progenitors transplanted to the hippocampus migrate on host vasculature" (2016). Faculty Scholarship. 197.
Introduction
There is a functional interdependence between the vascular and nervous systems. The vasculature plays a substantive role in regulating endogenous neural progenitor production (Eichmann and Thomas, 2013) , and in determining lineage specification of embryonic neural tissue (Acevedo et al., 2015) . During neural tube development, angiogenesis forms the subventricular plexus, vascularizing the embryonic neurogenic zone (Engelhardt, 2014) . The neurogenic niches of the adult brain, the subventricular zone (SVZ) and the subgranular zone (SGZ) of the hippocampus, are well vascularized (Bozoyan et al., 2012; Palmer et al., 2000; Shen et al., 2004; Sun et al., 2015) , with neural progenitors in close association with blood vessels (Palmer et al., 2000; Shen et al., 2004; Sun et al., 2015; Tavazoie et al., 2008) . A functional role for this relationship is supported by the observation that endothelial cells promote neural stem cell proliferation (Shen et al., 2004) , and recent transcriptome analysis reveals spatial and temporal-specific expression of neurogenic factors by brain endothelial cells (Ottone et al., 2014) . Interestingly, other endothelial-derived signals such as vascular endothelial growth factor (VEGF), initially identified for its mitogenic role during vasculogenesis (Ferrara and Henzel, 1989) , also promote SVZ neural progenitor proliferation and maturation (Wittko et al., 2009) , whereas conditional knock-out of the VEGF gene in endothelial cells inhibits neurogenesis (Cao et al., 2004) .
In addition to supplying a source of growth factors and signaling molecules, blood vessels also provide a physical framework that can support the migration of neural progenitors during development and in the adult brain (Whitman et al., 2009 ). In the embryonic and adult rodent SVZ, newly born progenitors migrate along blood vessels toward the olfactory bulb via the rostral migratory stream (RMS) (Bovetti et al., 2007; Kokovay et al., 2010; Snapyan et al., 2009 ). The vasculature also provides guidance cues for the tangential migration of GABAergic progenitors from the embryonic germinal zones to the mouse cortex (Won et al., 2013) . In stroke, there is an increase in angiogenesis around the infarct site (Hayashi et al., 2006) , and endogenous neural stem cells and neuroblasts migrate along blood vessels to repopulate damaged regions (Madri, 2009; Thored et al., 2007; Yamashita et al., 2006) .
A variety of molecular interactions promote the initial association between blood vessels and SVZ neural progenitors and the subsequent migration of the progenitors. The integrin α6β1 on the neural progenitor surface promotes binding to laminin-coated blood vessels, and this interaction is key to the subsequent exit of neural progenitors from the SVZ to join the RMS (Kokovay et al., 2010) . VEGF also acts as a chemoattractant, promoting the repopulation of neural progenitors to ischemic regions damaged by stroke (Marti et al., 2000; Wittko et al., 2009 ). The chemokine CXCL12 on the blood vessel surface helps direct the migration of SVZ neural progenitors (Kokovay et al., 2010) .
Astrocytes play a role in promoting vasculature-supported neural progenitor migration. Neural progenitors migrating along blood vessels in the SVZ are in direct contact with the astrocytes that coat these vessels (Bozoyan et al., 2012; Kaneko et al., 2010; Lois and Alvarez-Buylla, 1994) . During development, astrocytes help maintain the correct organization of the vasculature in the RMS (Bozoyan et al., 2012) . Lesioning the cortex can also activate endogenous SVZ neural progenitor cells and promote their migration to the site of injury, with a role for astrocyte/ blood vessel-derived CXCL12 reported (Saha et al., 2013) . Taken together, these studies suggest the importance of the blood vessel-astroglial environment in providing cues for directing neural progenitors to sites of injury.
Given the ability of endogenous neural progenitors to migrate on brain vasculature, we investigated the ability of embryonic stem cellderived neural progenitors (ESNPs) transplanted to the adult mouse brain to use blood vessels as a migratory substrate. This line of investigation is of particular interest given the potential use of ESNPs in cell replacement therapies to treat a variety of neurological disorders.
We now show that grafts of mouse embryonic stem cell (ESC)-derived ESNPs in the hippocampus are well vascularized, with an increase in blood vessel area over time, likely due to an inflammatory response triggered by the injection. Following transplant to the hippocampus, ESNPs are also found in close association with blood vessels at great distances from the injection site, consistent with the vasculature providing a migratory substrate. Both blood vessels and blood vessel-associated astrocytes are coated with CXCL12, and our previous work suggests a role for this chemokine in ESNP translocation (Hartman et al., 2010) . Using hippocampal slice culture, we observe a time-dependent association of ESNPs with blood vessels following deposition on the slice surface. We directly examined the interactions of ESNPs with brain endothelial cells (BECs) in vitro and observe striking morphological differences between ESNPs co-cultured with BECs and ESNPs grown alone. We demonstrate that BECs produce laminin and ESNPs express the α6β1 integrin and that a function-blocking antibody inhibits the adhesion of ESNPs to a BEC monolayer. In addition, we find that human ESNPs (hESNPs) migrate towards BECs in a Boyden chamber migration assay in response to BEC-secreted factors, including CXCL12. These data suggest that the astroglial-endothelial cell niche promotes the migration of ESNPs away from the initial site of deposition. Understanding the molecular cues that direct ESNP migration can aid investigators in accurately targeting therapeutic cell transplants to regions of damage.
Results

Lesion model and transplant vascularization
Our previous work demonstrated that transplanting mouse ESNPs (mESNPs) into the dentate gyrus (DG) creates a lesion, which leads to degeneration of the suprapyramidal layer of the granule cell layer (Hartman et al., 2010) . As previously reported, transplanted YC5/EYFP mESNPs, (see Materials and Methods and Supp. Fig. 1A ) repopulate the suprapyramidal layer ( Fig. 1A -C) and differentiate into granule neurons (Hartman et al., 2010) . To establish whether the disappearance of the suprapyramidal layer of the DG was caused by the presence of the mESNPs or is due to a lesion caused by fluid injection alone, we compared the suprapyramidal layer of the DG following injection of mESNPs versus culture medium containing only rhodamine labeled microspheres. The pressure of fluid injection alone is sufficient to destroy the suprapyramidal layer, based on the virtual absence of NeuNpositive cells at 28 days following injection (Supp. Fig. 2A-D) . The layer is not restored under this condition, indicating that endogenous progenitors cannot regenerate this granule cell layer (Supp. Fig. 2A-D) .
We next examined the extent of vascularization in the transplant region, or domain marked by microspheres. Three days after YC5/EYFP mESNP injection, CD31-positive blood vessels are readily visible within the transplant (Fig. 1A, A' ). Over time, there is an apparent increase in the vascular area within the transplant zone ( Fig. 1B, B' , C, C'). To determine whether this increase is due to the transplant or is attributable to the lesion alone, we compared the vessel area within a mESNP transplant to the vessel area within the domain marked by microspheres. The increase in vessel area over time in the microsphere-containing domain and the mESNP transplant are comparable ( Fig. 1D ). These data, combined with our observation that there is an increase in the number of activated microglia within the transplant region (data not shown), suggest that upregulation of angiogenesis is due to an inflammatory response elicited by the fluid injection, and not dependent upon the presence of mESNPs.
2.2. mESNPS migrate upon and exhibit a close association with host vasculature as they move away from the transplant site At 28 days after injection, a large Sox1:GFP/Ubi:RFP mESNP transplant (red) in the DG interfaces with a laminin-positive vascular plexus (green) (Fig 2A) . Upon examination, transplanted mESNPs were also consistently observed outside of the main area of the transplant. Fig. 2A ' shows transplanted mESNPs that have migrated to the molecular layer of the hippocampus and are closely associated with blood vessels. Fig. 2A " shows that mESNPs can travel great distances into the cortex, and are again associated with blood vessels. We are able to visualize the needle track of the injection (data not shown) and because it is not adjacent to the cells we observe, conclude that it is unlikely the mESNPs in the molecular layer or cortex were deposited along this trajectory upon injection ( Fig. 2 A' A"). These data suggest that transplanted mESNPs migrate extensively using the vasculature as a substrate, consistent with previous work demonstrating that endogenous neural progenitors can use blood vessels as a migratory scaffold (Kokovay et al., 2010; Whitman et al., 2009) .
As doublecortin (DCX) expression marks migratory neuroblasts, we examined the proximity of DCX-positive mESNPs to blood vessels ( Fig. 2B-D ). Fig. 2B and C show a large transplant of YC5/EYFP cells that fills the suprapyramidal layer of the DG 7 days following injection. Vessels within the transplant are visualized via expression of CD31 ( Fig. 2B , red; 2B'C', violet). Fig. 2B ' and C', corresponding to the boxes shown in Fig. 2B and C, document a transplanted ESNP (GFP-positive), DCX-positive cell closely associated with a CD31-positive blood vessel. This cell is located past the molecular layer of the hippocampus on a blood vessel just ventral to the pyramidal cell layer of CA3, approximately 250 microns away from the dorsal edge of the transplant. The open arrowheads point to the nucleus of the transplanted mESNP and the closed arrowheads point to the nucleus of an endothelial cell. To determine if mESNPs are found closer to blood vessels than expected randomly, we quantified the distance of GFP-positive mESNPs, DCXpositive/GFP-positive mESNPs, and endogenous DCX-positive cells from the nearest blood vessel in comparison to what would be expected for a randomly distributed cell ( Fig. 2D ). Both populations of mESNPs, as well as endogenous DCX-positive cells, are located closer to blood vessels than expected if cells were distributed randomly ( Fig. 2D, D' ). Although the average distance between each of the three cell populations and blood vessels does not differ ( Fig. 2D') , their relative distribution at distinct distances does, as shown in Fig. 2D . A random distribution of points throughout the hippocampus exhibits a Gaussian curve (blue bars in Fig. 2D ). In contrast, mESNPs and their DCX-positive neuroblast derivatives, as well as endogenous neuroblasts, are closer to blood vessels. More than half of the GFP-positive mESNPs are found within 10 microns of a blood vessel (green bars in Fig. 2D ). 33% of the DCX-positive transplanted mESNPs are found within 5 microns of a blood vessel (red bar, Fig. 2D ), whereas 15% of the endogenous DCXpositive cells are found in this domain (purple bar, Fig. 2D ). These data suggest that, amongst these cell types, mESNP-derived neuroblasts are most closely associated with the vasculature, consistent with their migration on the vessel surface.
Blood vessel-associated astrocytes express CXCL12
The chemokine CXCL12 plays a significant role in neural progenitor migration (Li and Ransohoff, 2008) . We previously demonstrated that mESNPs express the CXCL12 receptor CXCR4 and that the extent of mESNP migration after transplant to the hippocampus is attenuated in the presence of AMD3100, an inhibitor of the interaction between CXCL12 and CXCR4 (Hartman et al., 2010) . In that study, however, we did not investigate the association between ESNPs and blood vessels. Blood vessels and associated astrocytes are a source of CXCL12 (Virgintino et al., 2013) ; therefore we examined whether hippocampal vasculature is coated with CXCL12.
Astrocytes were identified using an antibody directed against GFAP, and blood vessels via isolectin B4 binding. Fig. 3A -C shows GFAPpositive astrocytes wrapped around a blood vessel located within the molecular layer of the hippocampus. CXCL12 is present along the vessels as well ( Fig. 3A and B ). Fig. 3D -F shows a group of blood vessels beneath the infrapyramidal layer of the DG. Patches of CXCL12 appear to coincide with vessel-associated astrocytes ( Fig. 3 E, F) . Intriguingly, GFAP-positive astrocytes that are not associated with blood vessels (arrowhead in 3E, F) are not CXCL12-positive, whereas those associated with the vasculature are (arrow in Fig. 3 E, F) . These data suggest that CXCL12 produced by blood vessel-associated astrocytes provides a chemotactic cue for the migration of CXCR4-expressing ESNPs. The vasculature itself may also be a source of CXCL12, or promote CXCL12 production by the overlying astrocytes (Robin et al., 2006) . These data are consistent with blood vessels providing the substrate for the ESNP migration observed within the hippocampus in our previous report (Hartman et al., 2010) .
hESNPs associate with blood vessels in hippocampal slice culture
We next investigated the interaction between hESNPs and blood vessels using hippocampal slices. hESNPs (see Materials and Methods and Supp. Fig. 1B ) were seeded onto hippocampal slices derived from postnatal day 5-7 mice and cultured for up to 24 hours. The hESNPs were identified using a human-specific antibody directed against the neural stem cell marker nestin. Six hours after deposition, hESNPs show a rounded morphology, with a dispersed distribution pattern at the surface of the slice (Fig. 4A ). Twelve hours after deposition, hESNPs show a more mature morphology, with extended processes, and an increased proximity to laminin-positive blood vessels ( Fig. 4B ). At both 12 and 24 hours, hESNPs are clustered in loose aggregates that surround a vessel ( Fig. 4B, C) . These clusters resemble the proliferative clusters found near blood vessels in the SGZ (Palmer et al., 2000) or the type C transit amplifying cell clusters found within the SVZ near blood vessels (Doetsch, 2003) . We measured the percent of cells at specific distances from the nearest blood vessel at each time point, and observe an apparent movement towards the vasculature over time, with the majority of hESNPs within 10 microns of a blood vessel after 12 hours (Fig. 4D ). The increased association of hESNPs with blood vessels observed at 12 and 24 hours could be attributed to selective survival of cells that have made this connection. This possibility suggests we would observe a decrease in the total hESNP population in the slice over time. We therefore counted the total number of hESNPs observed at each time point, and do not see a significant decrease in the total cell number (less than 15%, data not shown), suggesting that the association is not due to selective survival. hESNPs also are closely associated with blood vessels after transplant to the hippocampus (Supp. Fig. 3A-B ), as observed for mESNPs. We also examined hippocampal slices for expression of CXCL12 and observed the chemokine along blood vessels, consistent with a role in hESNP migration (Supp. Fig. 4A-B) . These data confirm that hESNPs selectively associate with blood vessels over time, consistent with the apparent migration of mESNPs observed following transplantation.
hESNPs adhere to a BEC monolayer and exhibit altered morphology
To more closely examine the interaction between hESNPs and vasculature, we turned to hESNP-endothelial cell co-culture using hESNPs expressing RFP under control of the ubiquitin promoter and BECs (see Materials and Methods). To determine whether hESNPs attach to a BEC layer, we plated endothelial cells into a 24-well plate or onto glass coverslips and 24 hours later plated hESNPs directly on top of the growing endothelial monolayer, or into control wells lacking BECs. By 18 hours, hESNP morphology in co-culture began to differ from that observed in the absence of BECs. Cultured alone, hESNPs were evenly distributed throughout the dish and were clearly visible as individual cells or in small clusters. Their somas appear relatively flat and well spread ( Fig. 5A-A') . In contrast, co-cultured with BECs, hESNPs formed multicellular aggregates arrayed as round clusters or long, thin chains ( Fig. 5B, B' ). Under this condition, the cells appear tightly packed and C, C' shows an ESNP located past the molecular layer that has a process extending from it that is both DCX-positive (B') and GFP-positive (C'). Open arrowheads in B' and C' point to the nucleus of a transplanted cell in direct contact with the soma of an endothelial cell (closed arrowhead). Nuclei were counter-stained with Hoechst. Scale bar = 50μm in B' and C'. D, Histogram depicting the percentage of transplant mESNPs (YC5/EYFP), transplant-derived DCX-positive mESNPs (YC5/EYFP/DCX), and endogenous DCX-positive cells, and their distance in microns to the nearest blood vessel. Data are mean ± SEM. Transplant-derived DCX-positive mESNPs were significantly different from random distribution (Mann-Whitney test, pb.05) as well as transplant mESNPs and endogenous DCX-positive cells (Kruskall-Wallis ANOVA, pb.01). D', The average distance from the nearest blood vessel was not significantly different between the three cell types (green, purple, and red bars), but all are different from the random distribution (blue bar). n=5 brains analyzed. Data are mean ± SEM. *pb0.05, Students T-test. Abbreviations: V-ventricle, DG-dentate gyrus, SPL-suprapyramidal layer of the dentate gyrus, IPL-infrapyramidal layer of the dentate gyrus, ML-molecular layer, CX-cortex. together, with minimal extension of processes ( Fig. 5B-B') . Interestingly, co-culture of neural progenitors with astrocytes promotes neuronal differentiation, but does not lead to the morphological changes observed for endothelial cell co-culture (Lim and Alvarez-Buylla, 1999; Song et al., 2002) . Preliminary data suggest astrocytes are a positive chemoattractant for ESNPs though not to the same extent as BECS.
To investigate long-term interactions between BECs and hESNPs, cultures were grown for up to 5 days. Antibody directed against Fig. 3 . Blood vessel-associated astrocytes are a source of CXCL12. Double immunolabeling of the hippocampus using antibodies against GFAP (white) to label astrocytes and CXCL12 (green) to label the chemokine. Blood vessels are labeled using isolectin B4 (red). A. Astrocytes wrapped around a blood vessel in the upper molecular layer of the hippocampus. B, CXCL12 associated with astrocytes and blood vessel. C. Tight association of the vessels with the astrocytes. Below the infrapyramidal layer of the DG of the hippocampus arrowheads point to a GFAP-positive astrocyte (white) that is CXCL12-negative (green) and not directly contacting a blood vessel (D, E, F). An arrow points to a GFAP-positive astrocyte (white) that is also expressing CXCL12 (green) and has direct contact with a blood vessel. Scale bars = 100μm, nuclei counterstained with Hoechst. V-ventricle, IPL-infrapyramidal layer, ML-molecular layer Fig. 4 . hESNPs seeded onto hippocampal slices in culture then fixed after 6, 12, and 24 hours. A-C, hESNPs positive for human nestin (green), laminin-positive blood vessels (red). Z-stack images were taken approximately 40 microns from the surface of the slice (A, B, C) . D, Histogram depicting the percentage of hESNPs at specific distances from blood vessels in microns at the different time points. There is an overall increase in the percentage of cells found near blood vessels over time. In the first two bins (0-5, 5-10 microns) there is a significant difference in the percent of hESNPs located close to blood vessels between 6 and 12 hours, and 6 and 24 hours, n=5-6 slices per timepoint. Data are mean ± SEM. *pb0.05, Student's T-test. Scale bars = 100μm. human nuclear (HuNu) antigen was used to detect the hESNPs, and endothelial cells were identified using isolectin B4-Biotin (IB4). By day 3, the majority of HuNu-positive hESNPs were contained within tight clusters ( Fig. 5C, C") . By day 5, these aggregates contained immature neurons based upon expression of βIII tubulin, visualized using the Tuj-1 antibody (Fig. 5D, D" ) demonstrating that hESNPs continue to differentiate in the presence of BECs. At these later time points, the hESNP clusters were less frequently located on top of a layer of BECs and had instead cleared the substrate so they directly contacted the dish at gaps in the BEC monolayer ( Fig. 5D-D" ). Interestingly, in many cases, BECs tightly encircled the hESNP nests ( Fig. 5D-D" ).
α6β1 integrin mediates hESNP adhesion to laminin
We next investigated the molecular basis of the initial adhesive interaction between BECs and hESNPs. Based on previous reports documenting a role for the integrin receptor α6β1 in neural progenitor adhesion to laminin on the vascular surface, we focused on these components (Emsley, 2003; Liesi et al., 1984; Shen et al., 2008) . We observed laminin deposits in BEC cultures (Fig. 6A, A' ) and membraneassociated α6β1 on nestin-positive hESNPs (Fig. 6B-B"' ). To determine whether α6β1 is involved in hESNP-BEC adhesion, we used the α6β1specific function-blocking GoH3 antibody. We observed a significant reduction in the number of cells attached to laminin in the presence of GoH3, but not in comparable concentrations of a control antibody (Fig. 6C ). We next investigated whether GoH3 can inhibit the binding of hESNPs to a BEC monolayer. We pre-incubated hESNPs with GoH3 or control IgG2a, and then plated the hESNPs on top of the endothelial cells. After 30 minutes, fewer GoH3-treated hESNPs remain attached in the presence of GoH3 compared to a control antibody (Fig. 6D ). This inhibition was no longer observed after 60 minutes, suggesting a transient adhesive interaction (data not shown) perhaps due to internalization of the receptor. These data suggest that hESNPs bind to laminin-coated endothelial cells via the α6β1 integrin receptor.
hESNPs migrate towards endothelial cells in part in response to CXCL12
Finally, we investigated whether endothelial cells could promote the migration of hESNPs in vitro, and whether the chemokine CXCL12 (Supp Fig. 4 ) could play a role (Fig. 7) . We observed deposits of CXCL12 protein in BEC cultures, indicating the presence of the chemokine (Supp. Fig. 4C,  D) . Using a Boyden chamber assay, we previously demonstrated that mESNPs migrate towards CXCL12, and that this migration is inhibited by AMD3100 (Hartman et al., 2010) . Using this assay, we now show that CXCL12 also promotes migration of hESNPs relative to a media control (Fig. 7A, green and purple bars) and that migration is reduced to control levels with the addition of AMD3100 (Fig. 7A, teal bar) , using a previously established dose-dependent concentration (Kokovay et al., 2010) . Migration is also promoted, to a greater extent than observed for CXCL12, by BECs plated in the lower chamber (Fig. 7A, blue  bar) .There is also a reduction in hESNP migration towards endothelial cells in the presence of AMD3100 (Fig. 7A, red bar) , but not to control levels. These data suggest that endothelial cell-derived CXCL12 promotes hESNP migration, but that BECs may produce additional chemoattractants.
To determine whether reduced levels of migration observed in the presence of AMD3100 were due to hESNP toxicity and cell death, we examined the survival and proliferation of hESNPs in the presence of the inhibitor. After 28 days of differentiation, hESNPs were incubated with AMD3100 for 24 hours in culture, then fixed and immunostained. The number of nuclei observed per field, as well as the extent of phosphohistone H3 expression, an indicator of cells in M phase, were comparable under control and AMD3100 conditions (Fig. 7B) . In addition, the fraction of cells expressing neural lineage markers was comparable under the two conditions (Supp. Fig. 5 ). These data suggest that the hESNP survival, proliferation, or differentiation were not affected by AMD3100 treatment. We conclude therefore that the reduction in number of cells passing through the filter is due to inhibition of migration in the presence of AMD3100.
Discussion
Using ESNPs to repair damaged tissue in neurodegenerative diseases is an attractive option, as these cells are more readily obtained than fetal material. Recent work on the relationship between neural stem cells and blood vessels (reviewed in (Bjornsson et al., 2015) as well as our own transplant work (Hartman et al., 2010) , prompted us to investigate the interaction of ESNPs with the host vasculature. We demonstrate here that transplanted ESNPs migrate extensively after initial injection, using the blood vessel-astroglial niche as a scaffold.
The migration of endogenous SVZ neural precursors on blood vessels has been well documented (Kokovay et al., 2010; Ottone et al., 2014; Saha et al., 2013; Shen et al., 2008) . In contrast, in the SGZ, neural progenitors are closely associated with the vascular plexus of the DG, but their migration on blood vessels has only recently been described (Sun et al., 2015) . Activated radial glia-like neural stem cells in the adult SGZ, clonally labeled using an inducible Ascl1 CreERT2 knockin mouse line, migrate tangentially on a bed of blood vessels in the SGZ (Sun et al., 2015) . This was the first report of tangential, as opposed to radial migration, by granule neuron progenitors in the hippocampus. Intriguingly, there are a number of parallels between the migration of these endogenous neural progenitors and the migration of mESNPs we described previously (Hartman et al., 2010) , and in this report. The activated endogenous SGZ neural stem cells migrate optimally between 3 and 7 days following lineage labeling, and less extensively over the next 1-2 months (Sun et al., 2015) . We observe optimal migration of mESNPs transplanted to the DG by 7 days post-injection, with little additional movement at one month (Hartman et al., 2010) . We also note a Fig. 7 . CXCL12 and BECs promote hESNP migration. A, Compared to control N2B27 media conditions (green bar), hESNP migration is promoted by CXCL12 (purple bar), and this migration is blocked by the addition of AMD3100 (teal bar). Migration is promoted by endothelial cells (blue bar) to a greater extent than CXCL12, and partially blocked by addition of AMD3100 (red bar) (Data are mean ± SEM, **pb0.001, ***pb0.0001, one-way ANOVA from control). A', Schematic illustrating the in vitro trans-well assay (modified from Kumar et al. 2011) (n = 4 inserts per group). B, Bars to the left depict Hoechst labeled cells per field, bars to the right depict percentage of phospho-histone H3-positive hESNPs. strong association with blood vessels for both mESNPs and hESNPs (Figs. 2, 3 and 5) . The blood vessel association is seen, for both endogenous progenitors and ESNPs, at both the nestin-positive neural stem cell and DCX-positive neuroblast stages. We also observe the blood vessel juxtaposition for both neural progenitor somas and processes, as reported for endogenous progenitors (Sun et al., 2015) . These similarities suggest that ESNPs nicely model an endogenous event.
The chemokine CXCL12 plays a role in neural progenitor migration in a number of settings during development and following injury. Our prior work established a role for CXCL12 in migration of mESNPs transplanted to the hippocampus, by demonstrating that AMD3100 could limit the extent of migration (Hartman et al., 2010) . We now show that endothelial cells and associated astrocytes can serve as a source of this chemokine. We previously demonstrated that mESNPs migrate towards CXCL12 in a Boyden Chamber assay, and that this migration was inhibited by AMD3100 (Hartman et al., 2010) . Using hESNPs, we observed similar results, with cells migrating towards CXCL12 protein and BECs in vitro, and this migration is significantly inhibited by AMD3100. This suggests that endothelial cell-derived CXCL12, acting via the CXCR4 receptor, plays a significant role in promoting ESNP migration. In the Boyden Chamber assay using BECs, however, residual migration is observed in the presence of AMD3100, suggesting that additional BEC-derived chemokines play a role, an idea supported by the literature (reviewed in (Segarra et al., 2015) ). Glioma cells use blood vessels as a migratory substrate to metastasize, and a role for CXCL12 has been established (Zagzag et al., 2008) . Inhibiting the glioma cell-blood vessel interaction using AMD3100 is currently being considered as part of a combinatorial approach to inhibiting glioma metastasis (NCT01339039).
As we progress towards clinical application, it is essential to have a complete understanding of the fate of neural progenitors posttransplantation, including an understanding of interactions with the host vasculature. Our observations that ESNPs migrate on host vasculature raise the concern that transplanted neural stem cells may relocate to distant sites, where they may form neural stem cell tumors if they remain undifferentiated (Germain et al., 2013) , or disrupt the existing circuitry if they differentiate into mature neurons. These concerns suggest that measures need to be taken to retain transplanted cells at the injection site, and prevent subsequent migration, though tumor formation at the initial injection site remains a concern.
Alternatively, for the treatment of neurodegenerative diseases in which therapeutic cells need to be present throughout the CNS, distribution of neural progenitors could be mediated by promoting the blood vessel interaction. Information gained from studying the molecular mechanism regulating neural progenitor migration on vasculature may also prove useful in designing approaches to target cells to specific sites of damage.
Experimental Procedures
Mouse and human embryonic stem cell culture and neural differentiation
Use of embryonic stem cells was approved by Wesleyan University ESCRO committee. YC5 mESCs constitutively expressing EYFP (Carpentino et al., 2008; Hartman et al., 2010) and Sox1:GFP(46C) (gift of Dr. Austin Smith) mESCs constitutively expressing RFP (Cai and Grabel, 2007) were grown and differentiated as described previously (Cai and Grabel, 2007; Hartman et al., 2010) . YC5 mESCs were differentiated as embryoid bodies for 5-9 days in neural expansion suspension media before transplant (Hartman et al., 2010) . Sox1:GFP mESCs were differentiated 7 days in culture and then replated after enzymatic dissociation, and further cultured for two days before transplant (Germain et al., 2013) . At the time of transplant 70%-90% of mESNPs were nestin-positive. Transplants were made using Sox1:GFP/ Ubi:RFP cells because they differentiate in monolayer without the need for an embryoid body intermediate. hES3 Nkx2.1:GFP and Nkx2.1:GFP/Ubi:mCherry cells were used for all hESNP experiments (Goulburn et al., 2011) . hESCs were differentiated into neural progenitors as described previously (Banda et al., 2015) . hESNPs were used when stocks of these cells became available, to provide data more relevant to future cell-based therapies. Stocks of hESNPs were frozen between days 18 and 28 of differentiation, and thawed 1-3 days before co-culture or deposition onto slices. For hESNP transplants, hESNPs were thawed at day 18 in neurobasal media (Banda et al., 2015) and cultured for an additional 3 days prior to transplant. Around 90% of the hESNPs were human neural stem cell marker Musashi 1-positive (Germain et al., 2013) at the time of transplant.
Surgical Procedures
All experimental procedures were approved by the Wesleyan University Animal Care and Use Committee. The mice were kept on a 12 h light/dark cycle at a constant temperature (22°C) with food and water ad libitum. 8-10 week old male male mice were injected with YC5/EYFP ESNPs (Figs. 1A-C, 2B-C) as outlined in (Hartman et al., 2010) or hES3 Nkx2.1:GFP/Ubi:mCherry (Supp. Fig. 3 ). Sox1-GFP/ Ubi:RFP cells were injected into the DG of 8-10 week old male 129SVE mice (Fig 2A) . hES3 Nkx2.1:GFP/Ubi:mCherry cells were injected into the DG of 8-10 week old male Nod.Cg-Prkdc SCID mice (Supp. Fig. 3 ). Animals were anaesthetized using inhalation of isoflurane (Sigma) and were fitted onto a stereotaxic frame (Kopf, Tujunga, CA). Of the 8 mice transplanted with YC5/EYFP ESNPs, 5 were immunostained and analyzed due to accurate targeting of the transplant injection to the DG. Coordinates for injection into the hippocampus were based on distance from Bregma; -1.95mm posterior, -1.95mm lateral, and -1.9mm ventral to the pial surface. 50,000 mESNPs or 100,000 hESNPs in 1μl of neural differentiation media were injected over 10 mins. Rhodamine-labeled microsphere (Polysciences, Warrington, PA) injections were also delivered via 1μl of neural differentiation media (Supp. Fig. 2 ). Incisions were sealed with veterinary-grade tissue adhesive. Histological processing and analysis were conducted as previously described (Hartman et al., 2010) .
Immunostaining
ESNPs were cultured on chamberslides or tissue culture dishes and immunostaining performed as previously described (Germain et al., 2013) . Primary antibodies were applied overnight at 4°C at the following dilutions: mouse anti-nestin, 1:250 (Millipore), mouse anti-human nestin, 1:1000 (Millipore), mouse anti-β III tubulin 1:1000 (Covance), mouse anti-CXCL12 1:50 (R&D systems) mouse anti-human nuclear antigen (HuNu) 1:1000 (Millipore), mouse anti-GFP 1:500 (Millipore), rabbit anti-CXCL12 1:500 (Abcam), rabbit anti-RFP 1:500 (Rockland), chicken anti-GFAP 1:1000 (Aves), chicken anti-GFP 1:2000 (Aves), rabbit anti-laminin 1:500 (Sigma), rabbit anti-phosphohistone H3 1:500 (Millipore), rabbit anti-musashi1 1:500 (abcam), rat anti-CD31 1:100 (BD Pharmingen), rat anti-α6 1:50 (Beckman Coulter), guinea pig antidoublecortin (DCX) 1:500 (Chemicon), and Isolectin B4 was used at 5μg/ml (Life Technologies). Appropriate secondary antibodies (Life Technologies and Jackson Labs) were diluted in blocking buffer. Enhanced yellow fluorescent protein (EYFP)-positive cells were visualized by using chicken anti-green fluorescent protein (GFP) (Aves labs) or rabbit anti-GFP diluted 1:1000 (Invitrogen), followed by Alexa-Fluor 488 (Jackson Labs). Red fluorescent protein (RFP)-positive cells were visualized using rabbit anti-RFP 1:500 (Rockland), followed by Alexa-Fluor 568 (Jackson Labs). Cell nuclei were labeled with Hoechst 33342 (Molecular Probes) diluted 1:10,000, and sections were mounted in gelvatol.
Slice Culture and seeding of human ESNPs
Organotypic hippocampal slice cultures were prepared from P5-P8 129SVE mice of either sex (Taconic, Pennsylvania) and cultured using the interface method (Stoppini et al., 1991) on clear PTFE membranes (PICM03050, EMD Millipore). The hippocampi were sectioned into 300-400μm thick slices and cultured in MEM-based medium . Medium was changed twice a week. Microscopy was used to monitor the health of the slices in culture. 1.0×10 5 hESNPs in 0.2μl total volume were deposited on the surface of the slice preparation at the hilus of the DG or the molecular layer of the hippocampus. Immunohistochemistry of the slices was conducted following an established protocol (Gogolla et al., 2006) at antibody dilutions described above. Five random Z stacks (1 μm) per hippocampus (n = 4) were captured with a Zeiss LSM 510 Meta confocal microscope with LSM510 software. Distance of nestinpositive cell nuclei to the nearest blood vessel was quantified using the distance measurement in LSM510.
Endothelial cell culture
The bEnd.3 mouse brain endothelial cell line (BEC) was purchased from the American Type Culture Collection (ATCC) and expanded according to the supplier's recommendations. Upon confluence, cells were trypsinized and split 1:3. Cells were used between passage 3 and 10.
4.6. Direct neural progenitor-endothelial cell co-culture 24-well tissue culture plates (Falcon) or 12mm diameter glass coverslips (Falcon) were coated with poly-L-lysine (0.1mg/ml) and laminin (5mg/mL). Endothelial cells were seeded in endothelial cell culture medium at~4x10 4 cells/cm 2 . 24 hours later, endothelial cells were washed and the medium was changed to serum-free neural differentiation medium. Human ESNPs were thawed at day 25 and added directly on top of the endothelial cell layer at 4-6x10 4 cells/cm 2, , approximately 4 wells/coverslips per timepoint. Serum-free neural differentiation medium was changed every other day. After 18 hours to 5 days of co-culture, cells were washed in PBS and fixed in 3.7% formaldehyde for 10 minutes.
Adhesion assay and quantification
Eight-well glass chamberslides (Labtek) were coated with laminin at 37°C overnight. Human ESNPs were thawed at day 22 and preincubated with the integrin α6 subunit function-blocking antibody GoH3 (.2ug/mL, Beckman Coulter) or with control IgG2a antibodies (0.2ug/mL, Biolegend, R&D systems) in neural progenitor cell differentiation medium for one hour at 4°C. ESNPs were seeded at a density of 5x10 4 cells/cm 2 . After 30 or 60 minutes of attachment, cells were washed in PBS and fixed in 3.7% formaldehyde. For experiments with endothelial cells, BECs were seeded onto uncoated 96-well plates and grown to confluence in endothelial cell medium. The medium was then changed to serum-free neural differentiation medium. Two days later, day 23-25 hESNPs were plated on top of the BECs and allowed to attach for one hour before fixation. Nuclei were stained with Hoechst and cells mounted in gelvatol. A Retiga 2000R camera mounted on a Nikon Ti microscope and NIS elements imaging software were used for fluorescent imaging. The particle analyzer feature of NIS ImageJ was used to count total number of cells per well.
Chemotaxis/Boyden Chamber Assay
BECs were plated into 24-well tissue culture plates (Falcon) in BEC medium at 5x10 4 cells/cm 2 . Cell culture inserts with 8μm membrane pores (Falcon) were coated with laminin (5mg/mL). Once the BECs reached confluence (1-2 days after plating), the cells were washed in PBS and the medium was changed to serum-free neural progenitor differentiation medium. Two days later, day 21 hESNPs were seeded directly onto laminin-coated inserts at 1.5x10 5 cells/insert. The inserts were then moved into either control wells containing only hESNP differentiation medium, endothelial cells with or without AMD3100 (25μg/ml) (Sigma), or CXCL12 protein (200ng) (R&D) with or without AMD3100 (25μg/ml) (Sigma), 4 inserts per treatment group. Sixteen hours later, inserts were removed from the wells and rinsed. The membrane was fixed with 3.7% formaldehyde in PBS for 10 minutes, washed, and nuclei stained with Hoechst. The membrane was removed with a scalpel blade and applied to a slide with gelvatol. Fluorescent imaging was performed using a Retiga 2000R camera mounted on a Nikon Ti microscope and NIS elements imaging software. The total number of cells per insert was counted manually.
Data Acquisition and statistical analysis
In Fig. 1 , the vessel area per square micron was calculated by drawing a boundary around the GFP transplanted area and using NIS-Elements AR software and the autodetect program to measure the 568nm-expressing positively-labeled vessels. In Fig. 2 , the distance from each GFP-positive/DCX-positive, GFP-positive, and DCX-positive neuroblasts was quantified within the area of the hippocampus in 5 random sections triple-labeled with antibodies against DCX, CD31, and GFP. In Fig. 4 in each slice, the distance of each nestin-positive cell to the nearest blood vessel was measured in microns, with 5-6 slices per timepoint. All values are means ± SEM. Student's paired t-tests were used to assess the differences within groups and One-Way ANOVA or Mann-Whitney U test for differences between groups using StatPlus.
Supplementary data to this article can be found online at http://dx. doi.org/10.1016/j.scr.2016.02.043.
